Skip to main content
. 2014 Oct 17;2(6):828–839. doi: 10.1002/fsn3.178

Figure 8.

Figure 8

Influence of SPECTRA™ on circulating NO concentration in blood of human volunteers. Bioavailable NO level was analyzed in human blood according to material and methods described by protocol detection of circulating NOHb concentration in blood samples. Green column (placebo): 180 min after consumption of standard breakfast and placebo capsule; and Blue column (SPECTRA™): 180 min after consumption of standard breakfast and SPECTRA™ capsule. Data are mean ± SEM (n = 22), *P < 0.01 versus placebo.